cbdMD (YCBD) Other Working Capital Changes (2017 - 2025)
cbdMD (YCBD) reported Other Working Capital Changes of -$185214.0 for Q4 2025, little changed sequentially from -$184499.0 in Q3 2025.
cbdMD (YCBD) Other Working Capital Changes (2017 - 2025) Analysis & Trends
cbdMD (YCBD) has 7 years of Other Working Capital Changes data on file, last reported at -$185214.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes changed N/A year-over-year to -$185214.0; the trailing twelve-month figure through Dec 2025 stood at -$793568.0 (up 5.49% YoY), and the FY2025 full-year result was -$608354.0, up 47.16% from the prior year.
- Other Working Capital Changes was little changed at -$185214.0 in Q4 2025, from -$184499.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q3 2023 to a low of -$1.2 million in Q2 2023.
- A 5-year average of $21885.7 and a median of $31180.5 in 2024 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 78.2% in 2021, while the deepest fall reached 134.65% in 2021.
- Tracing YCBD's Other Working Capital Changes over 5 years: stood at -$321464.0 in 2021, then grew by 10.55% to -$287547.0 in 2022, then retreated by 8.39% to -$311661.0 in 2023, then soared by 35.35% to -$201497.0 in 2024, then gained by 8.08% to -$185214.0 in 2025.
- Business Quant data shows YCBD's Other Working Capital Changes at -$185214.0 in Q4 2025, -$184499.0 in Q3 2025, and -$182366.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 212,894.00 |
| Dec 31, 2025 | 212,894.00 |
| Dec 31, 2025 | 212,894.00 |
| Sep 30, 2025 | 40,116.00 |
| Sep 30, 2025 | 40,116.00 |
| Sep 30, 2025 | 40,116.00 |
| Jun 30, 2025 | -99,378.00 |
| Jun 30, 2025 | -99,378.00 |
| Jun 30, 2025 | -99,378.00 |
| Mar 31, 2025 | 38,113.00 |
| Mar 31, 2025 | 38,113.00 |
| Mar 31, 2025 | 38,113.00 |
| Dec 31, 2024 | 24,248.00 |
| Dec 31, 2024 | 24,248.00 |
| Dec 31, 2024 | 24,248.00 |
| Sep 30, 2024 | 470,437.00 |
| Sep 30, 2024 | 470,437.00 |
| Sep 30, 2024 | 470,437.00 |
| Jun 30, 2024 | -316,833.00 |
| Jun 30, 2024 | -316,833.00 |